HEPTEF 300mg
Composition:Ursodeoxycholic Acid 300mg Tablets
Use For:HEPTEF 300mg (Ursodeoxycholic Acid 300mg Tablets) is a medication used primarily for the treatment of gallstones and certain liver diseases, including primary biliary cirrhosis (PBC) and non-alcoholic fatty liver disease (NAFLD). Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid that helps to improve liver function and reduce the formation of gallstones.HEPTEF 300mg works by reducing the cholesterol content of bile, which prevents the formation of cholesterol-based gallstones. In individuals with liver diseases such as PBC, UDCA helps by decreasing the bile acid buildup that can damage liver cells, thereby slowing the progression of liver disease and improving liver function. It can also help in the dissolution of small cholesterol gallstones in patients who are not candidates for surgery.The recommended dosage is typically one to two tablets daily, depending on the condition being treated and the patient's response.
✅ HEPTEF 300 (Ursodeoxycholic Acid 300mg Tablets)
🔹 Product Overview:
HEPTEF 300 contains Ursodeoxycholic Acid (UDCA), a bile acid derivative used in the treatment of liver disorders such as primary biliary cholangitis, gallstone dissolution, and other cholestatic conditions. UDCA works by reducing the production of cholesterol in the liver and promoting its dissolution in bile, improving liver function and protecting liver cells from damage.
HEPTEF 300 is ideal for hepatologists and general practitioners treating chronic liver conditions, offering a well-researched and widely accepted therapeutic approach to hepatobiliary health. It is formulated with high bioavailability and precision to ensure clinical efficacy and patient safety.
🔹 Key Features:
Contains pharmaceutical-grade Ursodeoxycholic Acid 300mg
Effective in dissolving cholesterol gallstones and improving bile flow
Used in chronic liver diseases, cholestasis, and biliary cirrhosis
Manufactured in GMP-certified facilities
Available for PCD pharma franchise and third-party manufacturing
Excellent shelf life and blister packaging
🔹 Benefits:
Promotes liver detoxification and improved liver enzyme profile
Reduces itching and fatigue in cholestatic liver diseases
Non-surgical option for gallstone management
Trusted liver health product among physicians
🔹 How to Use:
Dosage must be determined by the physician based on liver condition
Usually taken 1–3 times a day with meals
Long-term use may be recommended in chronic liver conditions
Regular liver function tests may be advised during treatment
🔹 For PCD Pharma Franchise:
We offer HEPTEF 300 under our hepatic care division with full promotional materials, visual aids, monopoly rights, and excellent profit margins to support franchise partners.
🔹 For Third-Party Manufacturing:
We provide Ursodeoxycholic Acid 300mg Tablets with custom branding, bulk packaging options, and strict adherence to GMP/ISO standards for domestic and export supply chains.
KEYWORDS
Ursodeoxycholic Acid 300mg, HEPTEF 300 tablets, UDCA 300 franchise, liver care tablets, gallstone treatment medicine, cholestasis medicine, liver detox medicine, bile acid tablets, ursodeoxycholic acid suppliers, UDCA third-party manufacturing, hepatology PCD pharma, liver disease pharma products, UDCA PCD company, ursodiol 300mg tablets, primary biliary cirrhosis treatment, fatty liver franchise medicine, liver support tablets, chronic liver disease treatment, ursodeoxycholic acid contract manufacturing, gallstone medicine PCD company, UDCA WHO GMP, liver tablet ISO certified, liver care PCD distributor, ursodeoxycholic acid manufacturer India, gallstone medicine pharma franchise, liver enzyme support tablets, hepatobiliary medicine franchise, liver cleansing tablets, UDCA ISO pharma, chronic liver support capsules, gallstone dissolution pharma brand, ursodiol PCD support, best liver detox product, liver tonic replacement tablets, bile flow support medicine, liver therapy tablets, hepatic health PCD range, liver pharma contract manufacturing, liver doctor prescription medicine, bile thinning tablets, liver pharma exporter, gallstone PCD rights, liver care pharma kit, UDCA ISO certified manufacturer, hepatic segment PCD products, UDCA 300mg tablet suppliers, ursodiol bulk order, chronic cholestatic condition tablet, liver protection franchise products, liver segment pharma company, ursodeoxycholic acid exporters, UDCA marketing material, gallstone therapy drug, hepatoprotective medicine PCD, UDCA in liver cirrhosis, liver cell regeneration capsule, liver pharma wholesale, UDCA GI tolerance tablet, liver therapy medicine brand, gallstone removal tablet, liver condition pharma franchise, PCD pharma hepatic range, gallbladder support PCD franchise, liver care doctor-prescribed, bile acid support tablets, hepatologist recommended tablets, UDCA for fatty liver, ursodeoxycholic 300mg ISO unit, gallstone medical therapy, UDCA franchise marketing kit, liver capsule for PCD company, liver pharma visual aid, liver PCD product detailer, pharma for hepatobiliary health, gallstone dissolution non-surgical, ursodeoxycholic acid cost-effective supplier, UDCA tablets India pharma, liver therapy ISO exporter, liver health PCD monopoly, bile flow medicine GMP, UDCA in primary biliary cholangitis, liver medicine distributor rights, gallstone resolution capsule, liver regeneration pharma, UDCA PCD MR bags, liver protection ISO range, pharma liver specialist tablets, liver-focused PCD partners, hepatology medicine bulk supply, bile acid therapy tablet, liver support ISO label, bile salts formulation, gallstone free therapy, liver health capsule contract manufacturing, UDCA tablet packaging options, liver detoxifying tablets, hepatic drug pharma export, liver care medical sample, UDCA ISO contract manufacturer, UDCA 300mg tablet bulk export, hepatology focused pharma brand, bile acid capsules WHO GMP, liver specialist PCD collaboration, liver pharma brand India, gallstone therapeutic tablet, bile acid promoting product, liver tonic alternative tablet, liver pharma India third-party, UDCA non-invasive gallstone medicine, liver pharma WHO-GMP certified, pharma liver health exports, ursodiol support tablet brand, liver protection medicine company, UDCA prescription therapy, liver capsule long shelf life, PCD for liver function medicine, liver care PCD offers, gallstone pharma partner, UDCA liver wellness brand, hepatic segment third-party supplier, liver bile flow medicine, gallstone-free living capsule.ursodeoxycholic acid PCD pharma, UDCA franchise opportunity, liver tablets PCD franchise, bile acid pharma products, ursodiol liver care range, chronic liver disorder PCD supply, ursodeoxycholic pharma distributor, liver segment monopoly PCD, bile therapy tablet PCD, liver detox PCD brand, pharma franchise in liver care, liver health PCD promotion, ursodiol pharma division, bile support medicine PCD rights, UDCA franchise for liver segment, liver treatment drug PCD, gastroenterology PCD products, hepatology division franchise, ursodeoxycholic tablets for PCD, bile thinning agent PCD, liver wellness PCD collaboration, chronic liver PCD range, UDCA liver detox therapy, ursodeoxycholic pharma kit support, UDCA prescription PCD company, liver function therapy pharma brand, bile acid treatment PCD monopoly, WHO GMP UDCA PCD company, ISO certified liver care brand, liver support capsule PCD manufacturing, liver pharma expansion opportunity, hepatologist prescription tablet PCD, gallbladder support medicine franchise, bile therapy tablet for PCD, liver care product detailer, liver treatment PCD supplier, hepatology drug franchise opportunity.